China: Medlive Technology prepares Hong Kong listing

The largest online professional physician platform in China has hired Goldman Sachs and Haitong International to sponsor its planned Hong Kong IPO.

Medlive Technology is an online platform that has developed into an ecosystem for healthcare participants to gather, learn and discuss the latest research, products and technologies available in the healthcare market and clinical best practices. It has around 3.5 million registered users.

Medlive is exhibiting strong growth in its numbers. Revenues increased from Rmb83.5m (US$12.7m) in 2018 to Rmb121.6m in 2019 and further increased to Rmb213.5m in 2020, a CAGR of 59.9% from 2018 to 2020. Net profit increased from Rmb14.2m in 2018 to Rmb31.3m in 2019 and further increased to Rmb85.2m in 2020, at a CAGR of 145.0% from 2018 to 2020.

A US$500m deal could appear within the next three months, according to IFR.